
Sign up to save your podcasts
Or
In this solo episode of The Dr. Terri Show, Dr. Terri marks her 50th episode with a deep dive into one of today’s most talked-about medical breakthroughs—GLP-1 receptor agonists like semaglutide and tirzepatide. She explores the benefits, limitations, and long-term considerations of these popular medications, often used for weight loss and type 2 diabetes. Dr. Terri unpacks why so many people struggle to get off these drugs, what’s really happening with muscle loss and aging appearance, and how protein, fiber, and lifestyle play a critical role in sustainable health.
She also sheds light on the difference between brand name and compounded versions, why long-term safety data is still unknown, and how to approach these medications as a short-term tool—not a lifelong crutch. Whether you're on a GLP-1 or just curious, this episode offers actionable steps and crucial perspective from an integrative medicine lens.
---
The Dr. Terri Show is presented by Evexias Health Solutions.
Learn more about your ad choices. Visit megaphone.fm/adchoices
5
2525 ratings
In this solo episode of The Dr. Terri Show, Dr. Terri marks her 50th episode with a deep dive into one of today’s most talked-about medical breakthroughs—GLP-1 receptor agonists like semaglutide and tirzepatide. She explores the benefits, limitations, and long-term considerations of these popular medications, often used for weight loss and type 2 diabetes. Dr. Terri unpacks why so many people struggle to get off these drugs, what’s really happening with muscle loss and aging appearance, and how protein, fiber, and lifestyle play a critical role in sustainable health.
She also sheds light on the difference between brand name and compounded versions, why long-term safety data is still unknown, and how to approach these medications as a short-term tool—not a lifelong crutch. Whether you're on a GLP-1 or just curious, this episode offers actionable steps and crucial perspective from an integrative medicine lens.
---
The Dr. Terri Show is presented by Evexias Health Solutions.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1,276 Listeners
15,817 Listeners
4,801 Listeners
65 Listeners
161 Listeners
2,798 Listeners
808 Listeners
672 Listeners
46 Listeners
68 Listeners
1,505 Listeners
513 Listeners
62 Listeners
2,210 Listeners
1,141 Listeners
563 Listeners
322 Listeners
1,140 Listeners
74 Listeners
3,095 Listeners
11 Listeners